Showing 601-610 of 1328 results for "".
Ethical Neurologic Care During a Pandemic
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/ethical-neurologic-care-during-a-pandemic/31741/Our ethical duty is to provide equitable care, minimize harm, respect autonomy, and maintain trust.- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31094/In the evolving landscape of medical practice, effective online presence has become indispensable for neurologists. Over the past decade, the proliferation of physician websites has transformed how neurology practices attract and retain patients. However, many practitioners encounter unmet expectati
MS Minute: Disparities in Multiple Sclerosis: Incorporating Equity Into Clinical Care and Research
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-disparities-in-multiple-sclerosis-incorporating-equity-into-clinical-care-and-research/32018/Assessing biologic, genetic, and social factors of patients with MS to shrink the gap in care for underrepresented populations.The Multiple Sclerosis Prodrome: Past, Present, and Future
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-multiple-sclerosis-prodrome-past-present-and-future/31973/Multiple sclerosis may cause symptoms and disability prior to classically defined disease onset.Dementia Insights: Diagnosis and Management of Dementia With Lewy Bodies
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-diagnosis-and-management-of-dementia-with-lewy-bodies/32136/Knowledge of the latest research findings will equip neurologists with the clinical insight necessary to navigate the complexities of dementia with Lewy bodies, enhancing patient care and outcomes.Spinal Muscular Atrophy is Now a Treatable Genetic Condition
https://practicalneurology.com/diseases-diagnoses/neuromuscular/spinal-muscular-atrophy-is-now-a-treatable-genetic-condition/32025/Multiple therapy options are available for the treatment of people with spinal muscular atrophy, a genetic disorder presenting with a wide range of symptoms and severity.Stroke Snapshot: Incorporating Artificial Intelligence in Stroke Management: Redefining State of the Art
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-snapshot-incorporating-artificial-intelligence-in-stroke-management-redefining-state-of-the-art/32033/Artificial intelligence and machine learning tools can augment stroke management across the continuum of care, including prevention, prognostication, neuroimaging, diagnosis, treatment, and recovery.Epilepsy Essentials: Novel Interictal Biomarkers for Delineating the Epileptogenic Zone in Children With Drug-Resistant Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-novel-interictal-biomarkers-for-delineating-the-epileptogenic-zone-in-children-with-drug-resistant-epilepsy/32147/Novel interictal biomarkers of epilepsy are able to identify the epileptogenic zone with precision and predict surgical outcome in children with drug-resistant epilepsy.The Diagnosis of Functional Seizures
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/the-diagnosis-of-functional-seizures/31887/VideoEEG in the context of a complete clinical picture remains the gold standard for diagnosis of functional seizures.Epilepsy Essentials: EEG Findings Associated With COVID-19
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-eeg-findings-associated-with-covid-19/31712/Multiple EEG findings associated with COVID-19 suggest a potential prognostic role.